These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10650446)

  • 1. Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients.
    Schwarz MJ; Riedel M; Ackenheil M; Müller N
    Biol Psychiatry; 2000 Jan; 47(1):29-33. PubMed ID: 10650446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia.
    Stefanović MP; Petronijević N; Dunjić-Kostić B; Velimirović M; Nikolić T; Jurišić V; Lačković M; Damjanović A; Totić-Poznanović S; Jovanović AA; Ivković M
    J Psychiatr Res; 2016 Feb; 73():45-52. PubMed ID: 26679764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICAM G241A polymorphism and soluble ICAM-1 serum levels: evidence for an active immune process in schizophrenia.
    Kronig H; Riedel M; Schwarz MJ; Strassnig M; Moller HJ; Ackenheil M; Muller N
    Neuroimmunomodulation; 2005; 12(1):54-9. PubMed ID: 15756053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia.
    Schwarz MJ; Ackenheil M; Riedel M; Müller N
    Neurosci Lett; 1998 Sep; 253(3):201-3. PubMed ID: 9792246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating soluble intercellular adhesion molecule-1 in acute myocardial infarction: a possible predictor of reperfusion ventricular arrhythmias.
    Murohara T; Kamijikkoku S; Honda T
    Crit Care Med; 2000 Jun; 28(6):1861-4. PubMed ID: 10890633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity.
    Coll-Vinent B; Vilardell C; Font C; Oristrell J; Hernández-Rodríguez J; Yagüe J; Urbano-Márquez A; Grau JM; Cid MC
    Ann Rheum Dis; 1999 Mar; 58(3):189-92. PubMed ID: 10364919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.
    Grothey A; Heistermann P; Philippou S; Voigtmann R
    Br J Cancer; 1998 Mar; 77(5):801-7. PubMed ID: 9514061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated soluble intercellular adhesion molecule-1 levels are associated with poor short-term prognosis in middle-aged patients with acute ischaemic stroke.
    Rallidis LS; Zolindaki MG; Vikelis M; Kaliva K; Papadopoulos C; Kremastinos DT
    Int J Cardiol; 2009 Feb; 132(2):216-20. PubMed ID: 18191248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
    De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues.
    Krassas GE; Pontikides N; Doukidis D; Heufelder G; Heufelder AE
    Thyroid; 2001 Dec; 11(12):1115-22. PubMed ID: 12186498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder.
    Reininghaus EZ; Lackner N; Birner A; Bengesser S; Fellendorf FT; Platzer M; Rieger A; Queissner R; Kainzbauer N; Reininghaus B; McIntyre RS; Mangge H; Zelzer S; Fuchs D; Dejonge S; Müller N
    Bipolar Disord; 2016 Mar; 18(2):155-63. PubMed ID: 27016286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis.
    Ishii Y; Kitamura S
    Chest; 1995 Jun; 107(6):1636-40. PubMed ID: 7781359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy.
    De Bellis A; Di Martino S; Fiordelisi F; Muccitelli VI; Sinisi AA; Abbate GF; Gargano D; Bellastella A; Bizzarro A
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1222-5. PubMed ID: 9543145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients.
    Theodoropoulou S; Spanakos G; Baxevanis CN; Economou M; Gritzapis AD; Papamichail MP; Stefanis CN
    Schizophr Res; 2001 Jan; 47(1):13-25. PubMed ID: 11163541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis.
    Yang SS; Tsai G; Wu CH; Chen DS
    Hepatogastroenterology; 1996; 43(9):575-81. PubMed ID: 8799398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.
    Pradhan AD; Rifai N; Ridker PM
    Circulation; 2002 Aug; 106(7):820-5. PubMed ID: 12176954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.
    Sonnet E; Massart C; Gibassier J; Allannic H; Maugendre D
    J Endocrinol Invest; 1999 Jun; 22(6):430-5. PubMed ID: 10435852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.